Analyst Ratings for Rein Therapeutics (RNTX)
RNTX Rating Summary
RNTX Price Target Summary
- Highest: $8.00 (H.C. Wainwright)
- Lowest: $4.00 (Maxim Group)
- Average: $6.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.00 (+659.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$6.00 (+659.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/20/2026 | Maxim Group | Jason McCarthy | New Coverage | Buy (N/A) |
4.00 (N/A) |
0.86 (0.79) |
-8.14% | Details |
| 1/21/2026 | Brookline Capital Markets | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
1.20 (0.79) |
-34.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
